Boston Partners’s BioSpecifics Technologies Corp. BSTC Stock Holding History

Boston Partners’s Portfolio BSTC Stock Details BSTC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-35,169	Closed	-$1.86M	–	695
2020 Q3	$1.86M	Sell	35,169 -9,154	-21%	-$565K	﹤0.01%	433
2020 Q2	$2.72M	Sell	44,323 -2,775	-6%	-$161K	0.01%	394
2020 Q1	$2.66M	Buy	47,098 +4,647	+11%	+$265K	0.01%	399
2019 Q4	$2.42M	Buy	+42,451	New	+$2.25M	﹤0.01%	459

Other funds holding BSTC

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Boston Partners's BSTC Position: Q4 2020 in Review

Boston Partners sold out of BioSpecifics Technologies Corp. (BSTC) in Q4 2020, closing a stake of 35,169 shares — an estimated $1.86M sold.

Boston Partners first reported a position in BSTC in Q4 2019 and held it in 4 quarters. The position peaked at $2.72M in Q2 2020. 1 fund tracked by Wall St. Rank holds BSTC as of Q4 2020.

Boston Partners reported no remaining BioSpecifics Technologies Corp. position as of Q4 2020 after selling out during the quarter.
Boston Partners sold 35,169 BioSpecifics Technologies Corp. shares in Q4 2020, an estimated $1.86M.
Boston Partners first reported a position in BioSpecifics Technologies Corp. in Q4 2019 and held it in 4 quarters.
Boston Partners's BioSpecifics Technologies Corp. position peaked at $2.72M in Q2 2020.
1 fund tracked by Wall St. Rank held BioSpecifics Technologies Corp. as of Q4 2020.

Based on Boston Partners's 13F filing for Q4 2020, filed 4 Feb 2021.